PUMA BIOTECHNOLOGY INC

PBYI XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

410M

Short interest (Jul 15)

7.7%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.44%

↑ 2.4%

Available Shares

↑ 40.0%

Price Chart

Company Overview

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001401667

Asset Type: CS

Market Data

Market Cap: $406,177,658

Employees: 179

Status: Active

Short Interest

Current Borrow Fee 0.44%

Range: 0.35% - 0.44%

Available Shares 2M

Range: 1.7M - 1.7M

Recent Changes

Fee Change: ↑ 9.9%

Available Change: ↑ 10.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime